Cromos Pharma CEO highlights opportunities and challenges for small sponsors at MAGI Clinical Research Conference
Cromos Pharma CEO highlights opportunities and challenges for small sponsors at MAGI Clinical Research Conference   Cromos Pharma has successfully participated in MAGI’s Clinical Research Conference , Las Vegas, October 27-30, 2019. Dr. Vlad Bogin, Cromos Pharma CEO, led the panel discussion “Clinical Trials for Small Sponsors”. He was joined by Kevin M. Crawford (Head of Clinical Operations, Tenax Therapeutics), Matt Dickason (COO, ImmunogenX) and April Weir-Hauptman (Director, InClin). The
Cromos Pharma recruits 473 patients (92% of total) into a breast cancer trial, all in under 7 months.
Cromos Pharma recruits 473 patients (92% of total) into a breast cancer trial, all in under 7 months. Budapest, Hungary. We are happy to announce that Cromos Pharma has just completed the recruitment of a large registration breast cancer trial. The trial is being conducted in 9 countries and is being performed in collaboration with an international academic group. Initially contracted with recruiting 200 patients across 4 countries, Cromos has exceeded everyone’s expectations
Cromos Pharma celebrates Breast Cancer Awareness Month
Cromos Pharma celebrates Breast Cancer Awareness Month Breast cancer is the most commonly occurring cancer in women and the second only to lung cancer as the most common cancer overall. The developed nations in North America and Western Europe lead the world in incidence (well over 60 and up to 95 per 100,000 women ages 0-69). And yet, while mortality rates in

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us